The MacroGenics, Inc. ticker is MGNX and it is traded on the Nasdaq Global Market.
October 9, 2013.
9640 Medical Center Drive
Rockville, MD 20850
You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.
You can view our management team by visiting the Management section of our Investor Relations website.
Ernst & Young LLP
MacroGenics, Inc. does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.
MacroGenics, Inc. does not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.